Publications by authors named "Ruth Morse"

Claim this Profile
I
IL-6 knockdown in a model of the human bone marrow, abrogates DNA damage induction in bystander cells post-chemotherapy induced cytokine release syndrome.
Harshini S H Asurappulige, Michael R Ladomery, H Ruth Morse

Transl Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amylase production from marine sponge Hymeniacidon perlevis; potentials sustainability benefits.
Praise Tochukwu Nnaji, Emmanuel Adukwu, H Ruth Morse, Rachael U Chidugu-Ogborigbo

PLoS One· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotoxicity of cytokines at chemotherapy-induced 'storm' concentrations in a model of the human bone marrow.
Harshini S H Asurappulige, Adam D Thomas, H Ruth Morse

Mutagenesis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPHINX-Based Combination Therapy as a Potential Novel Treatment Strategy for Acute Myeloid Leukaemia.
Chigeru Wodi, Tareg Belali, Ruth Morse, Sean Porazinski, Michael Ladomery

Br J Biomed Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing.
Alexander R Vernon, Roy M Pemberton, H Ruth Morse

Mutagenesis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced genotoxic damage to bone marrow cells: long-term implications.
Jennifer E May, Craig Donaldson, Liana Gynn, H Ruth Morse

Mutagenesis· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.
Rachel M Hagen, Veronica S Chedea, Christopher P Mintoff, Elizabeth Bowler, H Ruth Morse

Int J Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel, physiologically relevant cytotoxicity model: application to the study of chemotherapeutic damage to mesenchymal stromal cells.
Jennifer E May, H Ruth Morse, Jinsheng Xu, Craig Donaldson

Toxicol Appl Pharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells.
Kevin Kemp, Ruth Morse, Kelly Sanders, Jill Hows, Craig Donaldson

Ann Hematol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy.
Kevin Kemp, Ruth Morse, Sarah Wexler, Christine Cox, Elizabeth Mallam

Ann Hematol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency.
Ahmad Gharehbaghian, Kharaja M G Haque, Carol Truman, Rachel Evans, Ruth Morse

Lancet· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis